Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE.

Slides:

Advertisements

Similar presentations

MAIN-COMPARE Study Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease.

Advertisements

Arterial Revascularization Therapies Part II: a nonrandomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with.

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Risk of Stroke With Coronary Artery Bypass Graft.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.

Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.

Robert A. Guyton, MD The Annals of Thoracic Surgery

Volume 54, Issue 1, Pages (August 2009)

Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.

Late survival in abdominal aortic aneurysm patients: The role of selective myocardial revascularization on the basis of clinical symptoms Martha M. Reigel,

Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

B. E. Backus, A. J. Six, J. C. Kelder, M. A. R. Bosschaert, E. G

Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with.

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016 Angela C. Webster, PhD, Evi V. Nagler, MD,

Robert A. Guyton, MD The Annals of Thoracic Surgery

Safety and efficacy of everolimus-eluting bioresorbable vascular scaffolds versus durable polymer everolimus-eluting metallic stents assessed at 1-year.

A meta-analysis of bed rest versus early ambulation in the management of pulmonary embolism, deep vein thrombosis, or both Nadia Aissaoui, Edith Martins,

Short- and intermediate-term outcomes of hybrid coronary revascularization for double- vessel disease Nirav C. Patel, MD, Jonathan M. Hemli, MD, Michael.

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

Peter K. Smith, MD The Annals of Thoracic Surgery

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Incident diabetes in clinical trials of antihypertensive drugs

Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies J. James Edelman,

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

(p = 0.32 for noninferiority)

One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 study

Percutaneous revascularization strategies in a patient with previous coronary artery bypass surgery: Technical and patho-physiological insights Pierfrancesco.

The use of functional tests and planned coronary angiography after percutaneous coronary revascularization in clinical practice.Results from the AFTER.

Anomalous right coronary artery originating from the left anterior descending artery: Case report and review of the literature Joel Wilson, Hassan Reda,

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus.

Sajjad Raza, MD, Joseph F. Sabik, MD, Stephen G. Ellis, MD, Penny L

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

For everything there is a season

Survival probability loss from percutaneous coronary intervention compared with coronary artery bypass grafting across age groups Umberto Benedetto,

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Long-term follow-up of mitral valve regurgitation��Importance of mitral valve pathology and left ventricular function on survival Krister Lindmark,

To bypass or stent? The changing rules of an advancing game

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE.

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A.

Weekend versus weekday mortality in ST-segment elevation acute myocardial infarction patients between 1985 and 2008 Sanne M. Snelder, Sjoerd T. Nauta,

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Trends in mortality risks among 94,328 patients surviving 30days after a first isolated coronary artery bypass graft procedure from 1987 to 2006: A population-based.

Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis.

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Glenn N. Levine et al. JACC 2011;58:e44-e122

CLINICAL OUTCOMES OF TREATMENT BY PERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFT SURGERY IN PATIENTS WITH CHRONIC KIDNEY DISEASE.

Davide Capodanno et al. JCIN 2009;2:

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

The Clinical Significance and Management Implications of Chronic Total Occlusion Associated With Surgical Coronary Artery Revascularization Lorenzo Azzalini,

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

M. N. Vicenzi, T. Meislitzer, B. Heitzinger, M. Halaj, L. A

Revascularization in severe ventricular dysfunction (15% ≤ LVEF ≤ 30%): a comparison of bypass grafting and percutaneous intervention Koichi Toda, MD,

Presentation transcript:

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry Hanim Sen, Ming Kai Lam, Kenneth Tandjung, Marije M. Löwik, K. Gert van Houwelingen, Martin G. Stoel, Hans W. Louwerenburg, Frits H.A.F. de Man, Gerard C.M. Linssen, Jan G. Grandjean, Carine J.M. Doggen, Clemens von Birgelen International Journal of Cardiology Volume 176, Issue 3, Pages 885-890 (October 2014) DOI: 10.1016/j.ijcard.2014.08.036 Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions

Fig. 1 PCI per time interval from CABG to index PCI in patients with previous CABG. The distribution of patients in time intervals from CABG to index PCI for the two patient groups (65 patients with PCI in graft lesions vs. 132 patients with PCI in native coronary lesions only). Analysis based on 197/202 patients with knowledge of exact time interval. Among the 17 pts. who underwent PCI in native coronary vessels during 0–1year from previous CABG, 9 were treated in grafted and 8 in ungrafted coronary arteries. International Journal of Cardiology 2014 176, 885-890DOI: (10.1016/j.ijcard.2014.08.036) Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions

Fig. 2 Target vessel revascularization during follow-up of 1year. A: Kaplan–Meier cumulative incidence curves at 1-year for target vessel revascularization for patients with versus without prior CABG. B: Kaplan–Meier cumulative incidence curves at 1-year for target vessel revascularization for patients with prior CABG treated for graft lesions versus lesions in native coronary vessels only. International Journal of Cardiology 2014 176, 885-890DOI: (10.1016/j.ijcard.2014.08.036) Copyright © 2014 Elsevier Ireland Ltd Terms and Conditions